Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
IJ Amat‐Santos, JP Sánchez‐Luna… - European Journal of …, 2022 - Wiley Online Library
Aims Despite aortic stenosis (AS) relief, patients undergoing transcatheter aortic valve
implantation (TAVI) are at increased risk of developing heart failure (HF) within first months …
implantation (TAVI) are at increased risk of developing heart failure (HF) within first months …
Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registry
J Baranowska, C Törngren, SJ Nielsen… - European Heart …, 2022 - academic.oup.com
Aims The association between the use of statins, renin–angiotensin system (RAS) inhibitors,
and/or β-blockers and long-term mortality in patients with aortic stenosis (AS) who …
and/or β-blockers and long-term mortality in patients with aortic stenosis (AS) who …
Effects of renin–angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation
U Fischer-Rasokat, C Baensch… - European Heart …, 2022 - academic.oup.com
Aims The objective of the study was to determine the effect of renin–angiotensin system
inhibitors (RASI) on the survival of subgroups of patients with aortic stenosis after …
inhibitors (RASI) on the survival of subgroups of patients with aortic stenosis after …
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers After Transcatheter Aortic Valve Replacement: A Meta-Analysis
Background Persistent left ventricular hypertrophy after transcatheter aortic valve
replacement (TAVR) has been associated with poor outcomes. Angiotensin-converting …
replacement (TAVR) has been associated with poor outcomes. Angiotensin-converting …
[HTML][HTML] Outcomes of renin‐angiotensin inhibitors following transcatheter aortic valve implantation
A Hosseinpour, R Gupta - Clinical Cardiology, 2024 - ncbi.nlm.nih.gov
(1) This paper is not under consideration elsewhere;(2) None of the paper's contents have
been previously published (3) All authors have read and approved the manuscript; and (4) …
been previously published (3) All authors have read and approved the manuscript; and (4) …
Negative Prognostic Impact of Mineralocorticoid Receptor Antagonist in Elderly Patients Receiving TAVR
T Imamura, N Narang, H Onoda, S Tanaka… - Journal of clinical …, 2023 - mdpi.com
Background: Morbidity and mortality following trans-catheter aortic valve replacement
(TAVR) remain high. Renin-angiotensin system inhibitors improve clinical outcomes in the …
(TAVR) remain high. Renin-angiotensin system inhibitors improve clinical outcomes in the …
The clinical outcomes of reni-angiotensin system inhibitors for patients after transcatheter aortic valve replacement: A systematic review and meta-analysis
S Wang, X Lin, Y Guan, J Huang - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Aims The objective of our systematic reviews and meta-analysis is to evaluate the clinical
outcomes of RAS inhibitors for patients after TAVR. Methods and results We performed a …
outcomes of RAS inhibitors for patients after TAVR. Methods and results We performed a …